Biotech Better Than Pharma For Combo Product Partnerships?
This article was originally published in The Gray Sheet
Executive Summary
Device makers may find more suitable partners for developing combination products in biotechnology firms, as opposed to pharmaceutical giants with fundamentally different business models, according to Medtronic's Lothar Krinke